Patentscanada
Supreme Court of Canada Rules 7-2 Against Patentability of Medical Treatment Methods but Upholds Janssen’s Dosing Regimen Patent
In a landmark 7-2 decision, the Supreme Court of Canada reaffirmed that methods of medical treatment are not patentable under Canadian law, a principle upheld for over 50 years. However, the Court ruled that Janssen Inc.’s patented dosing regimen for its schizophrenia drug INVEGA SUSTENNA does not constitute a method…
Friday, July 17, 2026